Hyperfine (HYPR) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
21 May, 2026Opening remarks and agenda
Meeting called to order at 10:00 A.M. Eastern Time and held as a live webcast to maximize stockholder participation.
Board members and executive team introduced, including representatives from the accounting firm and legal counsel.
Agenda and notice of meeting confirmed, with a quorum present for voting.
Board and executive committee updates
Five directors nominated for election to serve until the 2027 annual meeting, with no other nominations received.
Shareholder proposals
Proposals included election of directors and ratification of the independent registered public accounting firm.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Hyperfine
- Q2 2026 revenue up 45% YoY, margin above 50%, and strong global adoption outlook.HYPR
Q2 2026 - Portable MRI innovation fuels rapid growth, clinical adoption, and global expansion.HYPR
Jefferies Global Healthcare Conference 2026 - Up to 1,083,335 shares registered for resale, with proceeds from warrant exercises funding operations.HYPR
Registration filing - Q1 2026 revenue surged 83% to $3.9M, margin hit 51%, and cash runway extends into 2028.HYPR
Q1 2026 - Director elections, auditor ratification, and executive pay updates under controlled company governance.HYPR
Proxy filing - Vote on five director nominees and auditor ratification at the May 2026 virtual meeting.HYPR
Proxy filing - Q4 2025 revenue up 128% year-over-year; 2026 guidance targets 55% growth and margin gains.HYPR
Q4 2025 - Record Q2 revenue, raised 2024 guidance, and global expansion signal accelerating growth.HYPR
Q2 2024 - Portable AI-powered brain MRI drives growth and expands access in neurology care.HYPR
Jefferies Global Healthcare Conference